UCB 4019
Alternative Names: UCB4019Latest Information Update: 28 Oct 2019
At a glance
- Originator UCB
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for phase-I development in Unspecified(In volunteers, In adults) in United Kingdom (SC, Injection)
- 16 Aug 2016 Phase-I clinical trials in Undefined indication (In adults, In volunteers) in United Kingdom (SC) (NCT02873767)